InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Zaremba Rabourn Amy. Insider active across 2 companies, notably Ocuphire Pharma, Inc.. Aggregated, 10 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €20k. Activity tracked since 10 January 2023. The latest transaction was filed on 23 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Zaremba Rabourn Amy is a declarant linked to Opus Genetics, Inc. and Ocuphire Pharma, Inc., where the person is Head of Fin. Quality Assurance and SVP of Finance. The declarant has 10 filings in total, and across the recent filings observed between 2023-01-12 and 2026-04-27, sales total 20225 EUR and the most frequent transaction nature is Attribution.